RecruitingPhase 4NCT06007547

Prophylactic Minimally Invasive Surfactant Evaluation

Sponsor

Endeavor Health

Enrollment

200 participants

Start Date

Jan 1, 2024

Study Type

INTERVENTIONAL

Conditions

Premature Birth Respiratory Distress Syndrome, Newborn

Summary

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

Eligibility

Max Age: 15 Minutes

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Poractant Alfa for people with premature birth and respiratory distress syndrome, newborn. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 15 Minutes.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.